Hemgenix, manufactured by CSL Behring, will cost $3.5 million per treatment and is a gene therapy to treat adults with haemophilia B, a genetic ...
https://www.google.com/url?rct=j&sa=t&url=https://metro.co.uk/2022/11/25/most-expensive-drug-approved-for-haemophilia-at-3500000-a-dose-17828108/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0T_Bwh8WZt358QBhU4PK2L
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.